Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 898,573 | 977,062 | 790,107 | 579,745 | 217,511 |
| Depreciation Amortization | 355,744 | 427,961 | 462,059 | 380,293 | 375,870 |
| Income taxes - deferred | -81,410 | -137,351 | -139,549 | -81,555 | -106,337 |
| Accounts receivable | -99,227 | -100,442 | -57,565 | -70,701 | -37,009 |
| Other Working Capital | 3,559 | -351,482 | 174,342 | -79,760 | -103,285 |
| Other Operating Activity | 547,434 | 259,150 | 333,051 | 290,732 | 494,518 |
| Operating Cash Flow | $1,624,673 | $1,074,898 | $1,562,445 | $1,018,754 | $841,268 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 29,991 | N/A | N/A | N/A |
| PPE Investments | -173,055 | -165,646 | -275,954 | -267,437 | -124,096 |
| Net Acquisitions | -157,428 | N/A | -25,000 | -95,789 | -303,451 |
| Purchase Of Investment | -1,992,886 | -3,592,205 | -3,184,197 | -2,968,916 | -1,959,365 |
| Sale Of Investment | 2,668,694 | 3,332,829 | 2,941,060 | 3,253,779 | 1,787,139 |
| Other Investing Activity | 0 | 0 | 178,218 | -208,209 | 0 |
| Investing Cash Flow | $345,325 | $-395,031 | $-365,873 | $-286,572 | $-599,773 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 12,275 | -178,716 | -5,399 | -11,860 |
| Debt Issued | N/A | N/A | 986,980 | N/A | N/A |
| Debt Repayment | -18,073 | -10,867 | -1,512,474 | -6,563 | N/A |
| Common Stock Issued | 183,486 | 47,810 | 178,486 | 489,180 | 146,959 |
| Common Stock Repurchased | -2,077,579 | -751,170 | -738,938 | -2,991,184 | -320,268 |
| Other Financing Activity | 127,247 | -22,199 | 30,037 | 1,780,627 | 36,759 |
| Financing Cash Flow | $-1,784,919 | $-724,151 | $-1,234,625 | $-733,339 | $-148,410 |
| Exchange Rate Effect | -7,370 | 3,788 | 776 | -558 | 124 |
| Beginning Cash Position | 581,889 | 622,385 | 659,662 | 661,377 | 568,168 |
| End Cash Position | 759,598 | 581,889 | 622,385 | 659,662 | 661,377 |
| Net Cash Flow | $177,709 | $-40,496 | $-37,277 | $-1,715 | $93,209 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,624,673 | 1,074,898 | 1,562,445 | 1,018,754 | 841,268 |
| Capital Expenditure | -173,055 | -165,646 | -275,954 | -284,106 | -198,312 |
| Free Cash Flow | 1,451,618 | 909,252 | 1,286,491 | 734,648 | 642,956 |